Journal: Scientific Reports
Article Title: Hypoxia-mediated rescue of retinal ganglion cells deficient in mitochondrial complex I is independent of the hypoxia-inducible factor pathway
doi: 10.1038/s41598-024-75916-x
Figure Lengend Snippet: Deletion of vhl does not prevent degeneration of ndufs4 -deficient retinal ganglion cells. (A) To assess for cell-specific recombination of floxed vhl , a flattened retina from a Vglut2-Cre;vhl loxP/loxP mouse was serially sectioned in 40-µm increments to collect tissue from the outermost to the innermost retinal layers (samples 1–5). PCR was performed on purified genomic DNA from each section to reveal the presence of vhl loxP/loxP that is non-recombined (2 loxP sites, 460 bp) and recombined (1 loxP site, 260 bp). The presence of the Vglut2-Cre transgene in the genomic DNA was also confirmed by PCR. The schematics to the right depict the beginning of the vhl locus pre- and post-recombination, showing the positions of the loxP sites flanking Exon 1 and the expected PCR product sizes resulting from a reaction in which two forward primers (F1 and F2) and one common reverse primer (Rcomm) are used. See Supplementary Fig. online for un-cropped gels. (B, C) Representative images of retinal flat mounts from control mice without the Cre transgene (left panel) and from mice with the indicated heterozygosity or homozygosity status for deletion of ndufs4 and vhl from RGCs at (B) P30 and (C) P45 time points. RGCs are immunolabeled with RNA-Binding Protein 1 (RBPMS1, green). Bar, 20 μm. In each graph below, the density of RGC somas for each genotype is quantified at distances of 0.5, 1.0, and 1.5 mm from the optic nerve head. Individual data points are overlaid on each bar. Statistical comparisons between groups are indicated above the bars, with the following significance designations: ns, not significant; *, p < 0.05; **, p < 0.01; ***, p < 0.001.
Article Snippet: Retinas were isolated, blocked in 5% goat serum in PBS with 0.3% Triton X-100, incubated with rabbit polyclonal anti-RBPMS1 primary antibody (1:500; Novus, NBP2-20112) in block for 5 days at 4 °C, and then incubated with anti-rabbit Alexa Fluor 488 (1:500; Invitrogen) overnight at 4 °C.
Techniques: Purification, Control, Immunolabeling, RNA Binding Assay